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and COX1/COX2 expressions in AA pathway increased in model group
and their expressions were down-regulated by ACEI drug captopril,
indicating that AA pathway was activated by up-regulation of RAAS.
As important signal-transducing proteins, JAK1/STAT3, NFkb and Akt
expressions all increased in model group remarkably. QSYQ treatment
could attenuate myocardial ﬁbrosis and this effecacy were further
approved by decreasing levels of collagen I, collagen III, MMP2 and
MMP9 in QSYQ group. RAAS pathway was inhibited by QSYQ, as
indicated by decreased AT1 and increased AT2 expressions. PLA2,
COX1 and COX2 expressions were also down-regulated in QSYQ group.
In addition, “therapeutic” QSYQ administration seemed to down-
regulate JAK1/STAT3, NFkb and Akt expressions which maybe play
important roles in myocardial ﬁbrosis.
CONCLUSIONS AA pathway in myocardial ﬁbrosis may be mediated
by activation of RAAS in HF model rats. QSYQ can exert anti-ﬁbrosis
effect by downregulating expressions of RAAS pathway, and subse-
quently inhibiting proteins in AA pathway. The mechanism of QSYQ
cardiac protective efﬁcacy may be through RAAS-JAK1/STAT3, Akt and
PLA2-COXs-NFkb pathways. Our study provides new insights into the
complicated mechanism of QSYQ in the clinical treatment of HF.
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OBJECTIVES To explore the safe range of lipopolysaccharide(LPS)
density and provide the experimental data for the related research of
human coronary artery smooth muscle cells (HCASMC) associated
with inﬂammation, we investigated the effects of different ratios of
LPS at different points on the growth of HCASMC cultivated in vitro.
METHODS The 3-5 generations of HCASMC was respectively seeded
onto 96-well plates, then co-incubated with different concentration of
LPS (0,0.01,0.1,0.5,1,5,10, and 100mg/ml) at different points (24,48,
and 72h). Then cell viability was determined via methylthiazolete-
trazolium (MTT) assay. We determined the optimal concentration
range and time of LPS for promoting the growth of HCASMC.
RESULTS The effect of LPS on the growth and proliferation of
HCASMC was related with the density and action-time. Beyond
certain density, the smaller action-time of LPS (0, 24, 48h) did not
inhibit the growth of HCASMC but could increase the growth of
HCASMC; The longer action-time of LPS (72h) with high dose (1-100mg/
ml) could obviously inhibit the growth of HCASMC and the inhibitory
rate increased with the increase in the concentration of LPS. Besides,
with the same density, the longer action-time would decrease the cell
viability of HCASMC more obviously.
CONCLUSIONS The low dose of LPS (<1mg/ml) cannot obviously
produce cytotoxicity of HCASMC, and 0.01mg/ml LPS with action-time
of 24h can maximize the proliferation of HCASMC, which can be used
in the experimental study of HCASMC cultured in the inﬂammation
condition.
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OBJECTIVES Adiponectin (APN) secreted from perivascular adipose
tissue (PVAT) is one of the important anti-inﬂammatory adipokines to
inhibit the development of atherosclerosis, but the underlying
mechanism has not been clariﬁed. In this study, we aimed to elucidate
how APN regulates plaque formation in atherosclerosis.
METHODS To assess the role of APN secreted by PVAT in atheroscle-
rosis progression, we performed PVAT transplantation experiments
on carotid artery atherosclerosis model: ApoE knockout (ApoE/)
mice with a perivascular collar placement around the left carotid ar-
tery in combination with a high-fat diet feeding.RESULTS Our results showed that the ApoE/ mice with PVAT
derived from APN knockout (APN/) mice exhibited accelerated
plaque volume formation compared to ApoE/mice transplanted
with wild-type littermate tissue. Conversely, autophagy in macro-
phages was signiﬁcantly attenuated in ApoE/mice transplanted with
APN-/- mouse-derived PVAT compared to controls. Furthermore, in-
vitro studies indicated APN increased autophagy in primary macro-
phages, as evidenced by increased LC3-I processing and Beclin1
expression, which was accompanied by down-regulation of p62.
Moreover, our results showed that APN promotes macrophage auto-
phagy by suppressing the Akt/FOXO3a signaling pathway.
CONCLUSIONS Our studies demonstrated that PVAT-secreted APN
suppresses plaque formation by inducing macrophage autophagy.
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OBJECTIVES To study the effect of Rosuvastatin (Rsv) on blood
pressure, vascular structure and vasodilatation function of 3rd grade
branch mesenteric in spontaneously hypertensive rats (SHRs).
METHODS Thirty-two male SHRs at 12 wks old were randomly divided
into 2 groups: Rosuvastatin (SHR-R, n¼16, 10mg$kg-1$d-1) and un-
treated controls (SHR, n¼16). Age- and weight-matched WKY rats
served as control s(WKY, n¼16). The control rats were administrated
equivalent distilled water. Systolic blood pressure (SBP) was deter-
mined by tail-cuff method before treatment, 4 and 8 wks after treat-
ment. The wall-to-lumen area ratios (W/L), the ratios of wall thickness
(WT) to lumen radius (LR) of 3rd grade branch mesenteric arteries were
assessed morphometrically. Endothelium-dependent relaxation
(EDdR), endothelium-independent relaxation (EDiR) were measured
by PowerLab biological signal analytical system. Serum 25-Hydrox-
yvitamin D(25(OH)D) was determined by ELISA.
RESULTS SBP in Rsv-treated rats was signiﬁcantly lower than that in
untreated rats after 4,8 wks of treatment [SBP/mmHg, 4wks: SHR-R
180.0114.56 vs SHR 200.2713.94; 8wks: SHR-R 180.1313.46 vs SHR
189.8810.06, both P<0.01]. W/L and WT/LR in SHR-R showed a
descending tendency while exited no statistical difference after 4wks
treatment (P>0.05). Compared with untreated SHR, W/L [SHR-R
0.510.21 vs SHR 1.820.96, P<0.01] and WT/LR [SHR-R 0.230.04 vs
SHR 0.530.29, P<0.01] of 3rd grade branch mesenteric arteries in Rsv-
treated rats were markedly lower than that of untreated SHR after
8wks treatment. WT/LR in Rsv-treated rats was similar to the level as
that of WKY( P>0.05). EDdR and EDiR of 3rd grade branch mesenteric
arteries were reduced in untreated SHR. After 4 wks treatment, EDdR
of 3rd grade branch mesenteric arteries was increased[Emax/%: SHR
29.107.35, SHR-R 47.4110.74, WKY 83.855.17; pD2: SHR 5.960.58,
SHR-R 6.390.90, WKY 8.340.21, both P<0.01]. EDiR was also
enhanced [Emax/%: SHR 46.1311.45, SHR-R 75.2320.10, WKY
96.282.68; pD2: SHR 5.560.23, SHR-R 6.720.44, WKY 7.840.13,
both P<0.01]. After 8 wks treatment, its continuing enhancement was
not statistically signiﬁcant for EDdR and EDiR. Compared with SHR,
serum 25 (OH) D is higher after 8 wks of R treated. [SHR-R 5.931.70 vs
SHR 3.500.51 ng/ml, P<0.01], but didn’t reach the level of that in
WKY[(15.231.55) ng/ml].
CONCLUSIONS The treatment of Rosuvastatin may mildly lower
blood pressure, increase the plasma level of 25(OH)D, attenuate
remodeling of 3rd grade branch mesenteric arteries, and ameliorate
vasodilatation function in SHRs. The increase of vasodilatation func-
tion was prior to improvement of vascular structure.
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OBJECTIVES Recent genome-wide association studies (GWAS) have
identiﬁed CELSR2-PSRC1-SORT1 variants on chromosome 1p13.3
associated with CAD and plasma lipoproteins based on populations of
European, eastern Asia, southern Asia, Middle-Eastern Asia, and Af-
rica Americans. Some loci were found to affect the risk of CAD and IS.
However, there were no data in the southern Chinese populations.
Our study was to assess the association of CELSR2-PSRC1-SORT1
